Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
20601
Image_2_Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.tiff
Published 2020“…We further found that IL-17A inhibited IFN-α2 production by modulating the expression of Interferon Regulatory Factor-5 (IRF-5), IRF-7, IFN-stimulated gene 49 (ISG-49), and Mx1 expression during CHIKV infection. …”
-
20602
Image_1_Interleukin-17A Facilitates Chikungunya Virus Infection by Inhibiting IFN-α2 Expression.tiff
Published 2020“…We further found that IL-17A inhibited IFN-α2 production by modulating the expression of Interferon Regulatory Factor-5 (IRF-5), IRF-7, IFN-stimulated gene 49 (ISG-49), and Mx1 expression during CHIKV infection. …”
-
20603
Mean fire return interval (mFRI) estimate 1976–2000.
Published 2016“…<p>Mean fire return interval (mFRI) estimate 1976–2000 (A), and its change from the historical period (1951–1975) (B). …”
-
20604
-
20605
-
20606
-
20607
Measurement of Na<sup>+</sup> ratio in the TE and blastocyst cross-sectional area in Group A.
Published 2025“…Group A included 11 embryos (Embryo Nos. 1–11) and demonstrated an initial decrease in Na<sup>+</sup> concentration within the ROI (correspomding to theTE), followed by either a plateau or a gradual increase. …”
-
20608
-
20609
DataSheet7_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20610
DataSheet6_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20611
DataSheet4_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20612
DataSheet1_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.PDF
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20613
DataSheet3_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20614
DataSheet2_Novel Starting Points for Human Glycolate Oxidase Inhibitors, Revealed by Crystallography-Based Fragment Screening.ZIP
Published 2022“…<p>Primary hyperoxaluria type I (PH1) is caused by AGXT gene mutations that decrease the functional activity of alanine:glyoxylate aminotransferase. …”
-
20615
-
20616
-
20617
Model sensitivity analysis to parameters: <i>k</i><sub>5,<i>P</i></sub>, <i>K</i><sub><i>a</i></sub>, <i>K</i><sub><i>PLC</i></sub>, <i>V</i><sub><i>SERCA</i></sub> and <i>β</i>.
Published 2021“…<b>(D)</b> Decreased <i>V</i><sub><i>SERCA</i></sub> (BV of 0.9 μM s<sup>-1</sup>) increased frequency and duration of the Ca<sup>2+</sup> signal to the point of observing constant activity, whereas increased <i>V</i><sub><i>SERCA</i></sub> decreased frequency to the point of loss of signal in a 60 minute simulation. …”
-
20618
-
20619
-
20620
DRP2B is partially required for flg22-induced endocytosis of FLS2.
Published 2014“…All experiments were repeated at least three independent times with similar results. Values are mean ± SE. Statistical analysis was done as in <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1004578#ppat-1004578-g001" target="_blank">Fig. 1</a>.…”